首页> 外文OA文献 >Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial

【2h】

Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial

机译：EBV阳性难治性或复发性霍奇金淋巴瘤患者接受异体干细胞移植后强度降低的同种异体干细胞移植后，采用供体衍生的LMP特异性CTL进行细胞免疫治疗：淋巴瘤细胞治疗联合会（LCTC）试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hochberg Jessica; Miller Renuka P.; Hanley Patrick J.; McCormack Sarah; Harrison Lauren; Militano Olga; Brand Phyllis; Bollard Catherine M.; Cairo Mitchell S.;
展开▼
作者单位

展开▼
年度 2015
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial [J] . Hochberg Jessica, Miller Renuka P., Hanley Patrick J., Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2015,第2Suppla1期

机译：EBV阳性难治性或复发性霍奇金淋巴瘤患者接受异体供体源性LMP特异性CTL的继发性细胞免疫治疗后强度降低的异基因干细胞移植：淋巴瘤细胞治疗联合会（LCTC）试验
2. Reduced-intensity and non-myeloablative allogeneic stem cell transplantation from alternative HLA-mismatched donors for Hodgkin lymphoma: a study by the French Society of Bone Marrow Transplantation and Cellular Therapy [J] . Gauthier J., Castagna L., Garnier F., Bone marrow transplantation . 2017,第5期

机译：从霍奇金淋巴瘤的替代HLA错配供体中减少强度和非髓鞘性同种异体干细胞移植：法国骨髓移植和细胞疗法的法国社会研究
3. Pretransplantation (18-F)fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non-Hodgkin lymphoma undergoing reduced-intensity conditioning followed by allogeneic stem cell transplantation. [J] . Dodero A, Crocchiolo R, Patriarca F, Cancer: A Journal of the American Cancer Society . 2010,第21期

机译：移植前（18-F）氟脱氧葡萄糖正电子发射断层扫描可以预测复发性霍奇金淋巴瘤或侵袭性非霍奇金淋巴瘤患者的强度降低，然后再进行同种异体干细胞移植。
4. Phase 1 Trial of Retroviral-Mediated Transfer of the Human MDR-1 In Patients Undergoing High-Dose Chemotherapy and Autologous Stem Cell Transplantation [C] . Charles Hesdorffer, Janet Ayello, Maureen Ward, Keio International Symposium for Life Sciences and Medicine . 2000

机译：逆转录病毒介导的人MDR-1转移的第1期试验在接受高剂量化疗和自体干细胞移植的患者中
5. Donor selection for patients undergoing allogeneic hematopoietic stem cell transplantation: Assessment of the priorities of Canadian hematopoietic stem cell transplant physicians. [D] . Tay, Jason. 2009

机译：接受同种异体造血干细胞移植的患者的供体选择：加拿大造血干细胞移植医生的优先事项评估。
6. Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [O] . Anna Sureda, Carme Canals, Reyes Arranz, 2012

机译：复发或难治性霍奇金淋巴瘤患者降低强度条件后进行同种异体干细胞移植。 HDR-ALLO研究的结果–一项由GrupoEspañolde Linfomas / Trasplante deMédulaOsea（GEL / TAMO）和欧洲血液和骨髓移植小组淋巴瘤工作组进行的前瞻性临床试验
7. Allogeneic stem cell transplantation after reduced intensity conditioning in patients with relapsed or refractory Hodgkin’s lymphoma. Results of the HDR-ALLO study – a prospective clinical trial by the Grupo Español de Linfomas/Trasplante de Médula Osea (GEL/TAMO) and the Lymphoma Working Party of the European Group for Blood and Marrow Transplantation [O] . Sureda, Anna, Canals, Carme, Arranz, Reyes, 2011

机译：复发或难治性霍奇金淋巴瘤患者降低强度条件后进行同种异体干细胞移植。 HDR-ALLO研究的结果–一项由GrupoEspañolde Linfomas / Trasplante deMédulaOsea（GEL / TAMO）和欧洲血液和骨髓移植小组淋巴瘤工作组进行的前瞻性临床试验

Reduced Intensity Allogeneic Stem Cell Transplantation Followed By Adoptive Cellular Immunotherapy with Donor Derived LMP Specific-CTLs in Patients with EBV Positive Refractory or Recurrent Hodgkin Lymphoma: A Lymphoma Cell Therapy Consortium (LCTC) Trial

著录项

引文网络

相似文献

相关主题

期刊订阅